Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial
-
KVH Announces Transformative Initiatives
-
Watsco Boosts Annual Dividend 10% to $10.80 Per Share
-
Boralex: Dividend Declaration
-
Interface Brings Interactive Monitoring to IPConfigure Orchid VMS Deployments
-
EPIC 2024 to Amplify New Voices and Ideas from Across HR Industry
-
Sibros Partners with Xos Trucks to Power the Xos Connected Ecosystem for Production Series Class 5 Through 8 Electric Commercial Vans and Trucks
-
LianBio Announces Completion of Strategic Review
-
Draganfly Selected as an Exclusive Partner of the Ulkatcho First Nation’s, Ulkatcho Group of Companies to provide UAV Solutions, Services, Training, Public Safety, and Emergency Response within the
-
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update
-
Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial
-
STAX Engineering Launches First Multi-Port Maritime Emissions Capture and Control System in California
-
Cielo Provides Update on Continued Progress and Milestones Achieved to Advance Carseland Bio-SynDiesel® Project
-
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
-
GlobalFoundries Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results
-
Akoustis Reports Second Quarter FY24 Results
-
Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung
-
Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility
-
Pico Announces Binance Plug-In for Corvil Cloud Analytics
-
ARKO to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
-
BlueGrace Logistics Guadalajara, Mexico Operations Open
-
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
-
IGadgets and CRANNS collaborate on promoting the CRANNS RB6 - Smart Alarm Disc Lock Redefines Two-Wheeler Security
-
Unitil Reports Year-End Earnings
-
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
-
Update: Stellantis Will Post Full Year 2023 Results at a New Time on February 15
-
Woodbridge International Announces Sale of Black Eagle Consulting, Inc. to RMA Companies
-
Form 8.3 - LondonMetric Property Plc
-
TSX Accepts Notice of Intention to Make Normal Course Issuer Bid
-
Flash News: OKX Wallet now integrated with Unilend Finance
-
Landsbankinn hf.: Offering of covered bonds
-
TransUnion Announces Fourth Quarter and Full-Year 2023 Results
-
Man Group PLC : Form 8.3 - UK Commercial Property Reit plc
-
G2 Drills 15m @ 6.3 g/t Au; 10.3m @ 3.7 g/t Au and 41.5m @ 0.75 g/t Au in new Discovery Area
-
Man Group PLC : Form 8.3 - Tritax Big Box Reit plc
-
Man Group PLC : Form 8.3 - Redrow plc
-
Man Group PLC : Form 8.3 - Barrat Developments plc
-
Form 8.3 - LondonMetric Property plc
-
Probe Gold Announces Updated PEA for Novador Project, Quebec; 23% increase in Average Annual Production to 255,000 ounces, Pre-Tax NPV5% of C$1.53 Billion, and Pre-tax IRR of 34.4%
-
Stallion Uranium Signs Definitive Agreement to Sell Non-Core Uranium Projects in Eastern Athabasca Basin
-
2024 CanTrust Index reveals low trust in building affordable housing and falling trust in Artificial Intelligence
-
Beam Global Announces New Federal Customers Placed First-Time Orders for EV ARC Solar-Powered EV Charging Systems
-
Sotherly Hotels Inc. Announces Refinancing Of Tampa Hotel
-
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors
-
Immuron achieves record Travelan® sales
-
RadNet, Inc. Announces Date of its Fourth Quarter 2023 Financial Results Conference Call
-
Power Solutions International (PSI) engines featured at World Ag Show
-
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
-
Quantexa Customers Achieved 228% ROI with Benefits of $34.8M in New Total Economic Impact Study
-
TRADING IN PANDORA A/S SHARES BY BOARD MEMBERS, EXECUTIVES AND ASSOCIATED PERSONS

